Our centre is beginning a new clinical trials study, this study will evaluate the effectiveness and long-term safety of an investigational topical medication for rosacea with pimples (papulopustular rosacea). Study participants must be 18 years of age or older with moderate to severe papulopustular rosacea. The time commitment for this study is approximately 13 months and involves about 18 visits to the study center.
The study is being conducted by Dermatologists who specialize in the assessment and treatment of rosacea.
If you are interested please contact our clinical trials manager, Olga Halperin at (416) 633-0001 ext. 4, today!